Displaying 21 to 40 of 45 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
MedMark Specialty pharmaceutical distributor |
United States | N/A |
||
|
|
NB Therapeutics A biopharmaceutical and medical device company. |
United States | N/A |
||
|
|
Neotropix Inc |
United States | N/A |
||
|
|
Neuronetics Inc |
United States | 1 Oct 2009 | Series D |
|
|
|
Neuronetics Inc |
United States | 1 May 2011 | Series E |
|
|
|
NovaSom Inc Provider of at-home diagnostic testing of obstructive sleep apnea (OSA) as an alternative to in-laboratory sleep studies |
United States | N/A |
||
|
|
NuPathe Inc Developer of branded therapeutics for neurological and psychiatric disorders. |
United States | N/A |
||
|
|
Optherion Inc |
United States | N/A |
||
|
|
Precision Therapeutics Inc Developer of support tools and services for individualized cancer treatment. |
United States | N/A |
||
|
|
Protez Pharmaceuticals Inc Developer of a small molecule antibiotics to address increasing bacterial resistance and chronic or recurrent infections. |
United States | N/A |
||
|
|
RainDance Technologies Inc |
United States | N/A |
||
|
|
Rapid Micro Biosystems Inc Provider of an innovative products for faster detection of microbial contamination. |
United States | N/A |
||
|
|
Regado Biosciences Inc |
United States | N/A |
||
|
|
Semprae Laboratories Inc Commercializing consumer products for female sexual health, including lead product Zestra® |
United States | N/A |
||
|
|
Sleep Solutions Inc |
United States | N/A |
||
|
|
TargetRx Inc Provider of insight to the pharmaceutical and biotech enterprises into the drivers of prescribing. |
United States | N/A |
||
|
|
Tarsa Therapeutics Inc Developer of an oral formulation of calcitonin for the treatment of osteoporosis |
United States | N/A |
||
|
|
TearScience Inc Developer of a diagnostic and treatment devices targeted at the root cause of the majority of dry eye cases. |
United States | 1 May 2010 | Series C Active |
|
|
|
Tengion Inc A leading regenerative medicine company. |
United States | N/A |
||
|
|
TetraLogic Pharmaceuticals A leader in the discovery and development of small molecule drugs called Smac mimetics for the treatment of cancers. |
United States | 1 Jun 2006 | Series B |